Table 3.
Multidrug resistance profiles of Campylobacter jejuni and Campylobacter coli.
| Multidrug Resistance Profiles | C. jejuni | C. coli | Total | |||
|---|---|---|---|---|---|---|
| (n = 106) % | (n = 49) % | |||||
| n | % | n | % | n | (%) | |
| AM-AMC-NAL-CIP-ERI-TET-CHL | 58 | 55% | 9 | 18% | 67 | 43.22% |
| AM-NAL-CIP-ERI-TET-CHL | 20 | 19% | 40 | 82% | 60 | 38.7% |
| AM-CIP-ERI-TET-CHL | 10 | 9% | 0 | 0% | 10 | 6.45% |
| NAL-CIP-ERI-TET-CHL | 12 | 11% | 0 | 0% | 12 | 7.74% |
| AM-ERI-TET-CHL | 6 | 6% | 0 | 0% | 6 | 3.87% |
n: number; AM: Amoxicillin; AMC: Amoxicillin/clavulanic acid; CIP: Ciprofloxacin; NAL: Nalidixic Acid; ERY: Erythromycin; TET: Tetracycline; CHL: Chloramphenicol; GEN: Gentamicin.